Trials / Completed
CompletedNCT00840268
A Study of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) Versus Vehicle in Dry Eye Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 427 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to demonstrate efficacy of Hydroxypropyl Guar Galactomannan 0.25% (HPGG) ophthalmic gel compared to Vehicle for the treatment of dry eye.
Detailed description
A 7-day Vehicle pre-randomization (run-in) phase during which all patients will receive 1 drop of Vehicle in each eye twice daily will precede the 21-day treatment phase, for an overall study duration of 28 days.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Hydroxypropyl Guar Galactomannan (HPGG) 0.25% ophthalmic gel | |
| DRUG | Hydroxypropyl Guar Galactomannan Vehicle | Inactive ingredients used as a placebo comparator |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2009-02-10
- Last updated
- 2014-07-17
Source: ClinicalTrials.gov record NCT00840268. Inclusion in this directory is not an endorsement.